Liting Yu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Liting Yu has a total of 29 co-authors. Here are the top co-authors by number of shared publications:
- Scott Bradley Crowe
Royal Brisbane and Women’s Hospital
7 shared publications Tanya Kairn
Royal Brisbane and Women’s Hospital, Herston, Australia
5 shared publications- Tanya Kairn
Royal Brisbane and Women’s Hospital
5 shared publications Alexander Livingstone
Royal Brisbane and Women’s Hospital, Herston, Australia
3 shared publicationsAnthony Baker
Royal Brisbane and Women’s Hospital, Herston, Australia
2 shared publications- Catherine S. Bettington
Royal Brisbane and Women’s Hospital
2 shared publications
Latest Publications
- 2 August 2026
- Published by Springer Nature
- p. 218-228
Processing Real-Time Target Tracking and Adaptation Data from the Radixact Synchrony System
- 2 August 2026
- Published by Springer Nature
- p. 218-228
Processing Real-Time Target Tracking and Adaptation Data from the Radixact Synchrony System
- Open Access
- 6 September 2023
- Published by Springer Nature in Physical and Engineering Sciences in Medicine
- Vol. 46 (4) , 1811-1817
Use of light-weight foaming polylactic acid as a lung-equivalent material in 3D printed phantoms
The 3D printing of lung-equivalent phantoms using conventional polylactic acid (PLA) filaments requires the use of low in-fill printing densities, which can produce substantial density heterogeneities from the air gaps within the resulting prints. Light-weight foaming PLA filaments produce microscopic air bubbles when heated to 3D printing temperatures. In this study, the expansion of foaming PLA filament was characterised for two 3D printers with different nozzle diameters, in order to optimise the printing flow rates required to achieve a low density print when printed at 100% in-fill printing density, without noticeable internal air gaps. Effective densities as low as 0.28 g cm− 3 were shown to be achievable with only microscopic air gaps. Light-weight foaming PLA filaments are a cost-effective method for achieving homogeneous lung-equivalency in 3D printed phantoms for use in radiotherapy imaging and dosimetry, featuring smaller air gaps than required to achieve low densities with conventional PLA filaments.
- 6 September 2023
- Published by Springer Nature in Physical and Engineering Sciences in Medicine
- Vol. 46 (4) , 1811-1817
Open AccessUse of light-weight foaming polylactic acid as a lung-equivalent material in 3D printed phantoms
The 3D printing of lung-equivalent phantoms using conventional polylactic acid (PLA) filaments requires the use of low in-fill printing densities, which can produce substantial density heterogeneities from the air gaps within the resulting prints. Light-weight foaming PLA filaments produce microscopic air bubbles when heated to 3D printing temperatures. In this study, the expansion of foaming PLA filament was characterised for two 3D printers with different nozzle diameters, in order to optimise the printing flow rates required to achieve a low density print when printed at 100% in-fill printing density, without noticeable internal air gaps. Effective densities as low as 0.28 g cm− 3 were shown to be achievable with only microscopic air gaps. Light-weight foaming PLA filaments are a cost-effective method for achieving homogeneous lung-equivalency in 3D printed phantoms for use in radiotherapy imaging and dosimetry, featuring smaller air gaps than required to achieve low densities with conventional PLA filaments.
- Open Access
- 23 May 2023
- Published by Springer Nature in Physical and Engineering Sciences in Medicine
- Vol. 46 (3) , 1033-1041
A structure-based gamma evaluation method for identifying clinically relevant dose differences in organs at risk
Gamma evaluation is currently the most widely used dose comparison method for patient specific quality assurance (PSQA). However, existing methods for normalising the dose difference, using either the dose at the global maximum dose point or at each local point, can respectively lead to under- and over-sensitivity to dose differences in organ-at-risk structures. This may be of concern for plan evaluation from clinical perspectives. This study has explored and proposed a new method called structural gamma, which takes structural dose tolerances into consideration while performing gamma analysis for PSQA. As a demonstration of the structural gamma method, a total of 78 retrospective plans on four treatment sites were re-calculated on an in-house Monte Carlo system and compared with doses calculated from the treatment planning system. Structural gamma evaluations were performed using both QUANTEC dose tolerances and radiation oncologist specified dose tolerances, then compared with conventional global and local gamma evaluations. Results demonstrated that structural gamma evaluation is especially sensitive to errors in structures with restrictive dose constraints. The structural gamma map provides both geometric and dosimetric information on PSQA results, allowing straightforward clinical interpretation. The proposed structure-based gamma method accounts for dose tolerances for specific anatomical structures. This method can provide a clinically useful method to assess and communicate PSQA results, offering radiation oncologists a more intuitive way of examining agreement in surrounding critical normal structures.
- 23 May 2023
- Published by Springer Nature in Physical and Engineering Sciences in Medicine
- Vol. 46 (3) , 1033-1041
Open AccessA structure-based gamma evaluation method for identifying clinically relevant dose differences in organs at risk
Gamma evaluation is currently the most widely used dose comparison method for patient specific quality assurance (PSQA). However, existing methods for normalising the dose difference, using either the dose at the global maximum dose point or at each local point, can respectively lead to under- and over-sensitivity to dose differences in organ-at-risk structures. This may be of concern for plan evaluation from clinical perspectives. This study has explored and proposed a new method called structural gamma, which takes structural dose tolerances into consideration while performing gamma analysis for PSQA. As a demonstration of the structural gamma method, a total of 78 retrospective plans on four treatment sites were re-calculated on an in-house Monte Carlo system and compared with doses calculated from the treatment planning system. Structural gamma evaluations were performed using both QUANTEC dose tolerances and radiation oncologist specified dose tolerances, then compared with conventional global and local gamma evaluations. Results demonstrated that structural gamma evaluation is especially sensitive to errors in structures with restrictive dose constraints. The structural gamma map provides both geometric and dosimetric information on PSQA results, allowing straightforward clinical interpretation. The proposed structure-based gamma method accounts for dose tolerances for specific anatomical structures. This method can provide a clinically useful method to assess and communicate PSQA results, offering radiation oncologists a more intuitive way of examining agreement in surrounding critical normal structures.
- Open Access
- 21 October 2022
- Published by Springer Nature in Research Square
A structure-based gamma evaluation method for identifying clinically relevant dose differences in organs at risk
Purpose Gamma evaluation is currently the most widely used dose comparison method for patient specific quality assurance (PSQA). However, existing methods for normalising the dose difference, using either the dose at the global maximum dose point or at each local point, can respectively lead to under- and over-sensitivity to dose differences in organ-at-risk structures. This may be of concern for plan evaluation from clinical perspectives. This study has explored and proposed a new method called structural gamma, which takes structural dose tolerances into consideration while performing gamma analysis for PSQA. Methods As a demonstration of the structural gamma method, a total of 78 retrospective plans on four treatment sites were re-calculated on an in-house Monte Carlo system and compared with doses calculated from the treatment planning system. Structural gamma evaluations were performed using both QUANTEC dose tolerances and radiation oncologist specified dose tolerances, then compared with conventional global and local gamma evaluations. Results Results demonstrated that structural gamma evaluation is especially sensitive to errors in structures with restrictive dose constraints. The structural gamma map provides both geometric and dosimetric information on PSQA results, allowing straightforward clinical interpretation. Conclusion The proposed structure-based gamma method accounts for dose tolerances for specific anatomical structures. This method can provide a clinically useful method to assess and communicate PSQA results, offering radiation oncologists a more intuitive way of examining agreement in surrounding critical normal structures.
- 21 October 2022
- Published by Springer Nature in Research Square
Open AccessA structure-based gamma evaluation method for identifying clinically relevant dose differences in organs at risk
Purpose Gamma evaluation is currently the most widely used dose comparison method for patient specific quality assurance (PSQA). However, existing methods for normalising the dose difference, using either the dose at the global maximum dose point or at each local point, can respectively lead to under- and over-sensitivity to dose differences in organ-at-risk structures. This may be of concern for plan evaluation from clinical perspectives. This study has explored and proposed a new method called structural gamma, which takes structural dose tolerances into consideration while performing gamma analysis for PSQA. Methods As a demonstration of the structural gamma method, a total of 78 retrospective plans on four treatment sites were re-calculated on an in-house Monte Carlo system and compared with doses calculated from the treatment planning system. Structural gamma evaluations were performed using both QUANTEC dose tolerances and radiation oncologist specified dose tolerances, then compared with conventional global and local gamma evaluations. Results Results demonstrated that structural gamma evaluation is especially sensitive to errors in structures with restrictive dose constraints. The structural gamma map provides both geometric and dosimetric information on PSQA results, allowing straightforward clinical interpretation. Conclusion The proposed structure-based gamma method accounts for dose tolerances for specific anatomical structures. This method can provide a clinically useful method to assess and communicate PSQA results, offering radiation oncologists a more intuitive way of examining agreement in surrounding critical normal structures.
- Open Access
- 8 February 2021
- Published by Springer Nature in Physical and Engineering Sciences in Medicine
- Vol. 44 (1) , 201-206
Comparison of global and local gamma evaluation results using isodose levels
The aim of this study is to evaluate the behaviour of global and local gamma analyses with isodose levels. Global and local gamma evaluation were performed on patient-specific quality assurance (PSQA) data from 100 volumetric modulated arc therapy (VMAT) arcs and 100 helical tomotherapy (HT) plans, using an in-house gamma code. Gamma pass rates versus isodose levels were plotted and evaluated. Other than a slightly increased skew towards higher pass rates for the global gamma evaluation, minimal differences were observed between the results of evaluating all VMAT arcs separately and the results of evaluating over VMAT treatment plans by combining arcs from each plan. Generally, the VMAT results showed average pass rates that increase with decreasing isodose level, for both global and local gamma evaluations. The HT results differed systematically from the VMAT results, with the results of performing global and local gamma evaluations agreeing more closely at all isodose levels and with the highest gamma pass rates being achieved at intermediate dose levels, between the 40 and 70% isodose levels. These results demonstrate the complex of relationships between global and local gamma evaluation results that can arise when clinical PSQA data are analysed and exemplify how the local gamma evaluation does not necessarily produce disproportionately reduced gamma pass rates in low dose regions. Performing gamma evaluation with different isodose levels is suggested as a useful method to improve understanding of specific PSQA data and as well as the broader features of gamma evaluation results.
- 8 February 2021
- Published by Springer Nature in Physical and Engineering Sciences in Medicine
- Vol. 44 (1) , 201-206
Open AccessComparison of global and local gamma evaluation results using isodose levels
The aim of this study is to evaluate the behaviour of global and local gamma analyses with isodose levels. Global and local gamma evaluation were performed on patient-specific quality assurance (PSQA) data from 100 volumetric modulated arc therapy (VMAT) arcs and 100 helical tomotherapy (HT) plans, using an in-house gamma code. Gamma pass rates versus isodose levels were plotted and evaluated. Other than a slightly increased skew towards higher pass rates for the global gamma evaluation, minimal differences were observed between the results of evaluating all VMAT arcs separately and the results of evaluating over VMAT treatment plans by combining arcs from each plan. Generally, the VMAT results showed average pass rates that increase with decreasing isodose level, for both global and local gamma evaluations. The HT results differed systematically from the VMAT results, with the results of performing global and local gamma evaluations agreeing more closely at all isodose levels and with the highest gamma pass rates being achieved at intermediate dose levels, between the 40 and 70% isodose levels. These results demonstrate the complex of relationships between global and local gamma evaluation results that can arise when clinical PSQA data are analysed and exemplify how the local gamma evaluation does not necessarily produce disproportionately reduced gamma pass rates in low dose regions. Performing gamma evaluation with different isodose levels is suggested as a useful method to improve understanding of specific PSQA data and as well as the broader features of gamma evaluation results.
- 1 October 2020
- Published by Elsevier in Physica Medica
- Vol. 78, 166-172
Exploring the gamma surface: A new method for visualising modulated radiotherapy quality assurance results
- 1 October 2020
- Published by Elsevier in Physica Medica
- Vol. 78, 166-172
Exploring the gamma surface: A new method for visualising modulated radiotherapy quality assurance results
- 27 May 2020
- Published by Springer Nature in Physical and Engineering Sciences in Medicine
- Vol. 43 (2) , 659-664
Characteristics of inverse gamma histograms
This work explores the characteristics of the inverse gamma histogram and its potential use as part of the patient specific quality assurance (PSQA) program for volumetric modulated arc therapy (VMAT). ArcCheck measured dose files and TPS predicted dose files were imported and analysed using the in-house inverse gamma code developed in the Python package. Inverse gamma with fixed distance-to-agreement of 2 mm were calculated for 23 VMAT arcs. Dose difference histograms were plotted for six arbitrarily selected arcs with the 95th and 90th percentile values calculated. Dose difference histograms enabled visualisation of the dose difference distribution information. The 95th and 90th percentile values are equivalent to the dose difference criteria where the gamma pass rate is 95% and 90% respectively. These values can be used as a guide to assess plan acceptability, especially for plans that failed the initial gamma evaluation. The inverse gamma histograms are demonstrated to be a useful tool for plan evaluation in addition to the traditional gamma evaluation method. It contains dose difference or distance-to-agreement distribution information, which could be clinically useful for plan evaluation.
- 27 May 2020
- Published by Springer Nature in Physical and Engineering Sciences in Medicine
- Vol. 43 (2) , 659-664
Characteristics of inverse gamma histograms
This work explores the characteristics of the inverse gamma histogram and its potential use as part of the patient specific quality assurance (PSQA) program for volumetric modulated arc therapy (VMAT). ArcCheck measured dose files and TPS predicted dose files were imported and analysed using the in-house inverse gamma code developed in the Python package. Inverse gamma with fixed distance-to-agreement of 2 mm were calculated for 23 VMAT arcs. Dose difference histograms were plotted for six arbitrarily selected arcs with the 95th and 90th percentile values calculated. Dose difference histograms enabled visualisation of the dose difference distribution information. The 95th and 90th percentile values are equivalent to the dose difference criteria where the gamma pass rate is 95% and 90% respectively. These values can be used as a guide to assess plan acceptability, especially for plans that failed the initial gamma evaluation. The inverse gamma histograms are demonstrated to be a useful tool for plan evaluation in addition to the traditional gamma evaluation method. It contains dose difference or distance-to-agreement distribution information, which could be clinically useful for plan evaluation.
- Open Access
- 15 October 2019
- Published by Wiley in Journal of Applied Clinical Medical Physics
- Vol. 20 (11) , 189-198
Analysis of dose comparison techniques for patient‐specific quality assurance in radiation therapy
Purpose: Gamma evaluation is the most commonly used technique for comparison of dose distributions for patient‐specific pretreatment quality assurance in radiation therapy. Alternative dose comparison techniques have been developed but not widely implemented. This study aimed to compare and evaluate the performance of several previously published alternatives to the gamma evaluation technique, by systematically evaluating a large number of patient‐specific quality assurance results.Methods: The agreement indices (or pass rates) for global and local gamma evaluation, maximum allowed dose difference (MADD) and divide and conquer (D&C) techniques were calculated using a selection of acceptance criteria for 429 patient‐specific pretreatment quality assurance measurements. Regression analysis was used to quantify the similarity of behavior of each technique, to determine whether possible variations in sensitivity might be present.Results: The results demonstrated that the behavior of D&C gamma analysis and MADD box analysis differs from any other dose comparison techniques, whereas MADD gamma analysis exhibits similar performance to the standard global gamma analysis. Local gamma analysis had the least variation in behavior with criteria selection. Agreement indices calculated for 2%/2 mm and 2%/3 mm, and 3%/2 mm and 3%/3 mm were correlated for most comparison techniques.Conclusion: Radiation oncology treatment centers looking to compare between different dose comparison techniques, criteria or lower dose thresholds may apply the results of this study to estimate the expected change in calculated agreement indices and possible variation in sensitivity to delivery dose errors.
- 15 October 2019
- Published by Wiley in Journal of Applied Clinical Medical Physics
- Vol. 20 (11) , 189-198
Open AccessAnalysis of dose comparison techniques for patient‐specific quality assurance in radiation therapy
Purpose: Gamma evaluation is the most commonly used technique for comparison of dose distributions for patient‐specific pretreatment quality assurance in radiation therapy. Alternative dose comparison techniques have been developed but not widely implemented. This study aimed to compare and evaluate the performance of several previously published alternatives to the gamma evaluation technique, by systematically evaluating a large number of patient‐specific quality assurance results.Methods: The agreement indices (or pass rates) for global and local gamma evaluation, maximum allowed dose difference (MADD) and divide and conquer (D&C) techniques were calculated using a selection of acceptance criteria for 429 patient‐specific pretreatment quality assurance measurements. Regression analysis was used to quantify the similarity of behavior of each technique, to determine whether possible variations in sensitivity might be present.Results: The results demonstrated that the behavior of D&C gamma analysis and MADD box analysis differs from any other dose comparison techniques, whereas MADD gamma analysis exhibits similar performance to the standard global gamma analysis. Local gamma analysis had the least variation in behavior with criteria selection. Agreement indices calculated for 2%/2 mm and 2%/3 mm, and 3%/2 mm and 3%/3 mm were correlated for most comparison techniques.Conclusion: Radiation oncology treatment centers looking to compare between different dose comparison techniques, criteria or lower dose thresholds may apply the results of this study to estimate the expected change in calculated agreement indices and possible variation in sensitivity to delivery dose errors.
- Open Access
- 7 July 2019
- Published by Wiley in Journal of Applied Clinical Medical Physics
- Vol. 20 (7) , 193-200
Technical note: A modified gamma evaluation method for dose distribution comparisons
Purpose: In this work we have developed a novel method of dose distribution comparison, the inverse gamma (IG) evaluation, by modifying the commonly used gamma evaluation method.Methods: The IG evaluation calculates the gamma criteria (dose difference criterion, ΔD, or distance‐to‐agreement criterion, Δd) that are needed to achieve a predefined pass rate or gamma agreement index (GAI). In‐house code for evaluating IG with a fixed ΔD of 3% was developed using Python (v3.5.2) and investigated using treatment plans and measurement data from 25 retrospective patient specific quality assurance tests (53 individual arcs).Results: It was found that when the desired GAI was set to 95%, approximately three quarters of the arcs tested were able to achieve Δd within 1 mm (mean Δd: 0.7 ± 0.5 mm). The mean Δd required in order for all points to pass the gamma evaluation (i.e., GAI = 100%) was 4.5 ± 3.1 mm. The possibility of evaluating IG by fixing the Δd or ΔD/Δd, instead of fixing the ΔD at 3%, was also investigated.Conclusion: The IG method and its indices have the potential to be implemented clinically to quantify the minimum dose and distance criteria based on a specified GAI. This method provides additional information to augment standard gamma evaluation results during patient specific quality assurance testing of individual treatment plans. The IG method also has the potential to be used in retrospective audits to determine an appropriate set of local gamma criteria and action levels based on a cohort of patient specific quality assurance plans.
- 7 July 2019
- Published by Wiley in Journal of Applied Clinical Medical Physics
- Vol. 20 (7) , 193-200
Open AccessTechnical note: A modified gamma evaluation method for dose distribution comparisons
Purpose: In this work we have developed a novel method of dose distribution comparison, the inverse gamma (IG) evaluation, by modifying the commonly used gamma evaluation method.Methods: The IG evaluation calculates the gamma criteria (dose difference criterion, ΔD, or distance‐to‐agreement criterion, Δd) that are needed to achieve a predefined pass rate or gamma agreement index (GAI). In‐house code for evaluating IG with a fixed ΔD of 3% was developed using Python (v3.5.2) and investigated using treatment plans and measurement data from 25 retrospective patient specific quality assurance tests (53 individual arcs).Results: It was found that when the desired GAI was set to 95%, approximately three quarters of the arcs tested were able to achieve Δd within 1 mm (mean Δd: 0.7 ± 0.5 mm). The mean Δd required in order for all points to pass the gamma evaluation (i.e., GAI = 100%) was 4.5 ± 3.1 mm. The possibility of evaluating IG by fixing the Δd or ΔD/Δd, instead of fixing the ΔD at 3%, was also investigated.Conclusion: The IG method and its indices have the potential to be implemented clinically to quantify the minimum dose and distance criteria based on a specified GAI. This method provides additional information to augment standard gamma evaluation results during patient specific quality assurance testing of individual treatment plans. The IG method also has the potential to be used in retrospective audits to determine an appropriate set of local gamma criteria and action levels based on a cohort of patient specific quality assurance plans.